Sophie Vandebroek V
Known title: DirectorCIK: 0001442078
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Revvity Announces Earnings Call, Analysts Upgrade Rating. Revvity has announced that it will conduct an earnings call on November 3, 2026. Analysts have upgraded the stock’s rating, citing stronger fundamentals and a positive outlook. Today’s trading saw unusual volume and the price is near its support level of $110.97 with an RSI of 68.9, indicating a moderately overbought condition.
Transaction History
| IDXX | ▲ Buy | Option Exercise | 257 | $0 | 5/7/2026 | View on chart |
| RVTY | ▲ Buy | Grant | 1,015 | $0 | 5/7/2026 | View on chart |
| RVTY | ▲ Buy | Grant | 1,265 | $0 | 5/7/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 945 | $316K | 2/17/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 945 | $594K | 2/17/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 519 | $326K | 2/17/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,279 | $363K | 5/9/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,279 | $628K | 5/9/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 262 | $0 | 5/6/2025 | View on chart |
| RVTY | ▲ Buy | Grant | 1,074 | $0 | 4/30/2025 | View on chart |
| RVTY | ▲ Buy | Grant | 1,338 | $0 | 4/30/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 344 | $145K | 11/27/2024 | View on chart |
| IDXX | ▼ Sell | Gift | 224 | $0 | 11/27/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 257 | $0 | 5/6/2024 | View on chart |
| RVTY | ▲ Buy | Grant | 977 | $0 | 5/1/2024 | View on chart |
| RVTY | ▲ Buy | Grant | 1,218 | $0 | 5/1/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,404 | $345K | 3/5/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,404 | $790K | 3/5/2024 | View on chart |
| RVTY | ▲ Buy | Grant | 217 | $0 | 2/15/2024 | View on chart |
| RVTY | ▲ Buy | Grant | 264 | $0 | 2/15/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 344 | $0 | 5/11/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,187 | $1.0M | 5/4/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 2,187 | $452K | 5/4/2023 | View on chart |
| IDXX | ▼ Sell | Gift | 500 | $0 | 5/4/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 224 | $0 | 5/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating
KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.